EPIX Pharmaceuticals, Inc.

ACTIVE

马萨诸塞州米德尔塞克斯县, Massachusetts, United Stateswww.epixpharma.comPrivate91 employeesEstablished: 1988-01-01

Clinical Trials

4 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1988

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

54.5%

Phase 3

9.1%

Trial Status Distribution

Active, not recruiting

36.4%

Completed

36.4%

Terminated

27.3%

Clinical Trials

Trials sponsored by this organization (11)

A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED,PARALLEL GROUP STUDY TO EVALUATE THEEFFICACY AND SAFETY OF PRX-03140 AS MONOTHERAPY INSUBJECTS WITH ALZHEIMER’S DISEASE

Active, not recruiting

Apr 2009236 participants

Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease

Phase 2

Terminated

interventional

May 2008236 participants

An Open-Label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

Phase 2

Terminated

interventional

May 200840 participants

A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil

Phase 2

Terminated

interventional

Apr 2008420 participants

A Efficacy Study of PRX-00023 in Patients With Major Depressive Disorder

Phase 2

Completed

interventional

Mar 2007330 participants

Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept

Phase 2

Completed

interventional

Oct 200680 participants

Phase II feasibility study to evaluate the safety and efficacy of EP-2104R for Magnetic Resonance Imaging of thrombi in the arterial vasculature and cardiac chambers

Active, not recruiting

Jun 200632 participants

Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

Phase 2

Completed

interventional

Jun 200672 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations